-transparent.png){kind=logo}
Biological activities of angiotensin II-(1-6)-hexapeptide [ANG-(1-6)] and angiotensin II-(1-7)-heptapeptide [ANG-(1-7)] were studied in 5 normal men and 3 patients with Bartter's syndrome. The angiotensins were infused iv in each subject from 0900 h to 0915 h at a rate of 21 nmol(16.8 micrograms)/kg X min and 18 nmol(16.2 micrograms)/kg X min for ANG-(1-6) and ANG-(1-7), respectively. In the normal men a significant rise in blood pressure was observed by the infusions of both peptides. Average increments of blood pressure for ANG-(1-6) were 17/14, 23/18, 22/15 and 17/14 mmHg at 2, 5, 10 and 15 min, respectively, and those for ANG-(1-7) were 19/15, 20/17, 13/13 and 15/13 mmHg at 2, 5, 10 and 15 min, respectively. The duration of pressor actions after the cessation of the infusions (T) was 10 min for ANG-(1-6) and 20 (for systolic) and 30 (for diastolic) min for ANG-(1-7). T for ANG-(1-6) was shorter than and T for ANG-(1-7) was similar to T for Ile5-angiotensin II (Ile5-ANG II) reported previously in 7 normal men 5 of whom were the same as examined in the present study. On the other hand, both peptides did not cause a rise in blood pressure in the 3 patients with Bartter's syndrome. Both angiotensins did not cause an increase in plasma aldosterone but did cause a significant decrease in plasma renin activity both in the normal men and in the patients. From these results and our previous observations of inactivity of angiotensin II-(5-8)-tetrapeptide, a pressor action of angiotensin II-(4-8)-pentapeptide, and pressor, renin-suppressing and steroidogenic actions of angiotensin II-(3-8)-hexapeptide in normal men, it is thought that ANG-(1-6) and ANG-(1-7) are bound to angiotensin II (ANG II) receptor in the peripheral arterioles and show pressor actions (less than 0.024% and less than 0.028% of Ile5-ANG II, respectively) and suppress renin mainly via short loop feedback and that the shortest biologically active ANG II molecules for pressor, renin-suppressing and steroidogenic actions are Tyr-Ile-His, Val-Tyr-Ile-His and Val-Tyr-Ile-His-Pro-Phe, respectively, in man. It is also evident that ANG-(1-6) is more rapidly metabolized than ANG-(1-7) or Ile5-ANG II in man.
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
February 1990,
Hypertension (Dallas, Tex. : 1979),
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
November 1976,
Circulation research,
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
April 2001,
Clinical chemistry,
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
April 1971,
The Journal of clinical endocrinology and metabolism,
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
September 1992,
Biopolymers,
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
March 1991,
International journal of peptide and protein research,
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
April 2000,
Hypertension (Dallas, Tex. : 1979),
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
September 1973,
Journal of medicinal chemistry,
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
December 1975,
The Journal of clinical endocrinology and metabolism,
T Kono, and
A Taniguchi, and
H Imura, and
F Oseko, and
M C Khosla
June 1988,
Proceedings of the National Academy of Sciences of the United States of America,
